Chardon Laurence, Dubourg Laurence, Barin-Le Guellec Chantal, Guinard Francis, Hannedouche Thierry, Halimi Jean-Michel, Mariat Christophe
Hospices civils de Lyon, Hôpital Edouard Herriot, Service de biochimie, Lyon, France.
Hôpital Femme Mère Enfant, Bron, France ; Néphrologie, Dialyse, HTA et Exploration fonctionnelle rénale, Hôpital Edouard Herriot ; Faculté de médecine Lyon Est, Université Lyon 1, Lyon, France.
Ann Biol Clin (Paris). 2019 Aug 1;77(4):371-374. doi: 10.1684/abc.2019.1455.
Direct measurement methods of glomerular filtration rate (GFR) are considered as the gold standard to assess kidney function. Following the withdrawal of the Proinuline Serb® specialty by the French National Health Surveillance Agency, iohexol remains the most suitable marker to replace inulin as the marker for GFR in France. The assay is performed by high performance liquid chromatography (HPLC) coupled with ultraviolet (UV) detection or by mass spectrometry. Plasma clearance measurement is the protocol of choice: single-sample protocols dominate, but multiple-sample protocols may be more accurate in specific situations to improve accuracy. In some cases, urinary clearance protocols may be proposed. National and international recommendations suggest using a GFR measurement as a confirmatory test in cases where the creatinine-based estimated GFR is inappropriate, ie clinical situations characterized by a significant alteration of muscle mass or volume distribution. The indications retained by the working group were graded according to the level of recommendations. The essential indications are the evaluation of living kidney donor, the monitoring of kidney allograft function at one year post-transplantation, drugs with narrow therapeutic range (anticoagulant, chemotherapy) in patients with inadequate estimation of GFR by creatinine and clinical research.
肾小球滤过率(GFR)的直接测量方法被视为评估肾功能的金标准。自法国国家卫生监督机构撤销Proinuline Serb® 专用产品后,碘海醇仍是法国最适合替代菊粉作为GFR标志物的物质。该检测通过高效液相色谱(HPLC)结合紫外(UV)检测或质谱法进行。血浆清除率测量是首选方案:单样本方案占主导,但在特定情况下,多样本方案可能更准确,以提高准确性。在某些情况下,可能会采用尿清除率方案。国家和国际指南建议,在基于肌酐的估算GFR不适用时,即存在肌肉量或容量分布显著改变的临床情况时,使用GFR测量作为确认性检测。工作组保留的适应证根据推荐级别进行分级。基本适应证包括活体肾供体评估、移植后一年肾移植功能监测、GFR通过肌酐估算不足的患者中治疗窗窄的药物(抗凝剂、化疗药物)以及临床研究。